已收录 268921 条政策
 政策提纲
  • 暂无提纲
Rho kinase and hypertension
[摘要] Arterial hypertension is a multifactorial disease that is characterised by increased peripheral vascular resistance often accompanied by smooth muscle cell hypertrophy and proliferation. Rho kinases (ROCKs) are the most extensively studied effectors of the small G-protein RhoA and abnormalities in RhoA/ROCK signalling have been observed in various cardiovascular disease including hypertension. The RhoA/ROCK-pathway is a key player in different smooth muscle cell functions including contractility, proliferation and migration. Furthermore, there is extensive crosstalk between RhoA/ROCK- and NO-signalling. Therefore, not only ROCK inhibitors but also NO-donators or pleiotropic agents like statins exert their beneficial effects on the cardiovascular system at least in part via Rho/Rho-kinase. (c) 2010 Elsevier B.V. All rights reserved.
[发布日期] 2010-12-01 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Rho kinase;Hypertension;NO-signalling;Rho kinase inhibitors;Statins [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文